Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Cullinan Therapeutics Inc (NASDAQ: CGEM) was $8.56 for the day, down -1.83% from the previous closing price of $8.72. In other words, the price has decreased by -$1.83 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
Our analysis of CGEM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 24.46 and its Current Ratio is at 24.46. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On May 01, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when Michaelson Jennifer sold 4,000 shares for $12.51 per share. The transaction valued at 50,040 led to the insider holds 95,760 shares of the business.
JENNIFER MICHAELSON bought 8,000 shares of CGEM for $101,440 on Jan 06 ’25. On Dec 24 ’24, another insider, AHMED NADIM, who serves as the President and CEO of the company, sold 8,400 shares for $11.87 each. As a result, the insider received 99,708 and left with 263,150 shares of the company.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $8.61. The 50-Day Moving Average of the stock is -20.54%, while the 200-Day Moving Average is calculated to be -46.85%.
Shares Statistics:
A total of 58.14M shares are outstanding, with a floating share count of 35.71M. Insiders hold about 38.67% of the company’s shares, while institutions hold 76.37% stake in the company.
